Skip to main content
Back to Equities

Granules India

GRANULES • Pharmaceuticals & Biotechnology

NSE

Last Price

₹909.30

Market Cap

₹22.53K Cr

Sector

Pharmaceuticals & Biotechnology

For educational/research use only. Not a recommendation to buy or sell.

At a glance

as of 2026-09-11
Halal +1.12% today

0% below its 52-week high

Price trend

Positive

Over the last 6 months, Granules India's share price has risen, doing better than 72% of Pharmaceuticals & Biotechnology stocks. It is trading above its 200-day average price.

Institutional activity

Strongly negative

Trading patterns over recent weeks show strong signs of institutions selling Granules India (buying score 2/10, selling score 6/10).

Model rank

Positive

Our model's 5-day return score puts Granules India ahead of 73% of NSE stocks. The model has low confidence in this score (46%).

Ease of trading

Low

Shares change hands easily; there are no signs of trading drying up (risk score 3/10).

Price vs profits

Above typical

The share price is 38× last year's profit per share — above the typical range for NSE stocks (15–30×).

The wider Indian market is in a downtrend (model 99% sure). This affects every stock's model rank.

Browse ready-made screens →
Loading price data...

Company Information

NSE CodeGRANULES
ISININE101D01020
SectorPharmaceuticals & Biotechnology
IndustryPharmaceuticals

About Granules India (GRANULES)

Granules India is an NSE-listed company operating in the Pharmaceuticals & Biotechnology sector, within the Pharmaceuticals industry (ISIN INE101D01020). This page brings together the quantitative research signals our models compute for GRANULES: a model-estimated 1-day, 5-day and 21-day return outlook, momentum and trend indicators, institutional-activity context derived from observed trading flows, a snapshot of valuation and quality fundamentals, and the instrument's Sharia-compliance status. All figures are produced by statistical models from historical data and are intended for research and educational purposes.

To read the page, treat the model-estimated return outlook as a relative ranking signal rather than a forecast of price — higher scores reflect stronger model-estimated momentum and trend alignment, not a target or guarantee. The momentum and trend indicators describe how Granules India's recent price action compares with its own history, while the fundamentals and institutional-activity context add longer-horizon and flow-based perspective. Nothing here is investment advice, a recommendation, or a solicitation to transact; always do your own research and consult a SEBI-registered adviser before making any decision.

The "typical range" we compare a price-to-earnings multiple against is a fixed band for all NSE stocks, not a sector-specific one. Everything on this page describes what our models measured; none of it is a recommendation to do anything.